Latest Posts › Food and Drug Administration (FDA)

Share:

COVID-19 Weekly Newsletter: U.S. Vaccination Effort Goes International

While actively launching new initiatives and incentives to boost the vaccination rate within its own population, the U.S. government this week announced its plans to share portions of its vaccine stockpile...more

COVID-19 Weekly Newsletter: WHO Sets Global Vaccine Goals for 2021

This week, the World Health Organization (WHO) laid out its goals for boosting vaccination rates worldwide and also asked world leaders to provide additional funding for global vaccination efforts. In other COVID-19...more

COVID-19 Weekly Newsletter: 60% of American Adults Have Received One Vaccine Dose

With vaccination rates climbing, this week marked an encouraging turn on the path to a more “normal” summer and avoiding a fall resurgence. FDA Opposes Antibody Testing To Evaluate Immunity Response - On Wednesday,...more

COVID-19 Weekly Newsletter: Positive Signs on Path to Normalcy, Teenagers Approved for Vaccines

The Centers for Disease Control and Prevention (CDC) made waves this week with its announcement that fully vaccinated individuals can begin congregating indoors. Coupled with the announcement that teenagers are eligible for...more

COVID-19 Weekly Newsletter: Guidance and Developments as Global Vaccination Continues

This week, the CDC announced updated guidance regarding outdoor gatherings, and the Department of Labor is advancing new workplace safety standards. Meanwhile, dwindling U.S. vaccination rates and global vaccine access are...more

COVID-19 Weekly Newsletter: Preventing the Next Pandemic

A recent study of one of the two mRNA-based vaccines revealed positive news on how long the vaccine will effectively prevent against COVID-19 infection. The pandemic has also revealed societal weaknesses that, if addressed,...more

COVID-19 Weekly Newsletter: 116 Million Vaccines

It was a largely encouraging week in the U.S. COVID-19 response, where the vaccination rollout continues to outpace initial goals. Elsewhere, the World Health Organization (WHO) weighed in on the idea of requiring...more

COVID-19 Weekly Newsletter: Leaders Ponder Return to Normalcy

With significant headway in the vaccine distribution and certain states already lifting COVID-19 restrictions, U.S. leaders are beginning to contemplate when we might return to some semblance of normalcy. Two Million...more

COVID-19 Weekly Newsletter: New Vaccines, Streamlined Shipment Coordination

Addressing new variants, coordinating vaccine shipments and the continued progress of a third vaccine highlighted this week in the COVID-19 response. Vaccine Manufacturers Tackle New Variant - Manufacturers of COVID-19...more

COVID-19 Weekly Newsletter: U.S. Suffers Deadliest Days for COVID-19

In an otherwise troubling week, there are some positive developments in the COVID-19 response, including progress in the development of a new vaccine. The Pandemic Is Far from Over: 4000 Lives Gone in One Day ...more

COVID-19 Weekly Newsletter: FDA Committee Recommends Vaccine Approval

A milestone in the vaccine approval process and a bipartisan relief package proposal highlighted a busy week in the COVID-19 response. COVID-19 Relief Package - This week, a group of bipartisan senators put forth the...more

COVID-19 Weekly Newsletter: Vaccine Update, Thanksgiving Guidance

The Centers for Disease Control and Prevention (CDC) is urging individuals to refrain from traveling for the Thanksgiving holiday, as many states and communities in the U.S. have begun to enact additional control measures in...more

COVID-19 Weekly Newsletter: Positive Developments in the Race for a COVID-19 Vaccine

Positive news is emerging on the vaccine front in the fight against COVID-19, as one vaccine candidate is reported to have prevented more than 90% of symptomatic infections in clinical trials, and another was granted a Fast...more

COVID-19 Weekly Newsletter: U.S. Eyes Third Wave as Scientific Understanding, FDA Actions Advance

As talks of a third wave of infections bubble up and political negotiations over another COVID-19 relief package continue to stall, the pressure is on for the health and life science fields to better understand and tamp down...more

COVID-19 Weekly Newsletter: Vaccine Development Progresses as Cases Spike in the U.S.

There are an average of 45,000 new COVID-19 cases in the United States daily, an increase of 8% from the previous week. States that were already on an upward trajectory are getting worse and hospitalizations are on the rise,...more

COVID-19 Weekly Newsletter: POTUS Tests Positive, Pharma Pushes Back on Vaccine Politics

President Trump announced Friday morning that he and First Lady Melania Trump tested positive for COVID-19, ending an eventful and politically charged week in the pandemic response. Earlier in the week, pharmaceutical...more

COVID-19 Weekly Newsletter: Case Count, Death Toll Both Rising as Public Health Officials Work to Instill Confidence in a Vaccine

As COVID-19 cases rise across the U.S. and the death toll tops a staggering 200,000, four public health officials expressed confidence in an eventual vaccine even as the public's confidence in the vaccine appears to be waning...more

COVID-19 Weekly Newsletter: Researchers Study Dining Risks, Asymptomatic Transmission

A recent report from the Centers for Disease Control and Prevention (CDC) revealed that dining out carries heightened risk of COVID-19 transmission, but did not reveal a similar heightened risk related to travel. Studies...more

COVID-19 Weekly Newsletter: Back-to-School Snags, Research Breakthroughs

Rising unemployment rates, continued deliberations on another federal relief package, and schools implementing remote learning after on-campus spikes in case rates marked an eventful week in the COVID-19 pandemic response....more

44 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide